Drugs / DC/KLH
last change Dec 2013 re-read 3 minutes ago

DC/KLH

Vaccine

Investigated by
Memorial Sloan Kettering Cancer Center · Rockefeller University

Trials 1

200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00893945 Jun 2007 → Dec 2013 brain neoplasm Rockefeller University Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as DC/KLH ClinicalTrials.gov intervention name — accepted as the source's own label NCT00893945 ↗
Modality Vaccine “This study involves cancer research and the purpose is to assess the safety and activity of a type of vaccine as immune therapy for cancer.” NCT00893945 ↗